[CITATION][C] Gruppo Neuro-Oncologico Bresciano. Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of …

S Grisanti, VD Ferrari, M Buglione, GM Agazzi… - J Neurosurg Sci, 2019